Navigation Links
Stem Cells Market Size To Reach $170.1 Billion By 2020: Grand View Research, Inc.
Date:10/1/2015

SAN FRANCISCO, October 1, 2015 /PRNewswire/ --

The global stem cells market size is expected to reach USD 170.15 billion by 2020, according to a new report by Grand View Research, Inc. The market is expected to grow because of increasing research and development to develop therapeutic solution for chronic diseases and the huge funding by the government for drug discovery and development to serve the large unmet medical needs.

     (Logo: http://photos.prnewswire.com/prnh/20150105/723757)

The WHO statistics on Cancer (2012) concluded that it is the leading cause for global mortality and morbidity, with around 14 million new cancer cases and 8.2 million cancer related deaths which is estimated to reach 22 million in next two decades. Stem cells in combination with gene therapy along with DNA repair is anticipated to be used to treat many intractable diseases and is classified under orphan drugs.

Browse full research report with TOC on "Stem Cells Market Analysis By Product (Adult Stem Cells, Human Embryonic Cells, Pluripotent Stem Cell, Natural Rosette Cells), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion, Sub-Culture), By Application (Regenerative Medicine, Drug Discovery And Development) And Segment Forecasts To 2020" at: http://www.grandviewresearch.com/industry-analysis/stem-cells-market                                              

The California's Stem Cell Agency has spent around USD 1.4 billion for stem cell research and still has USD 872 million to provide for the same. In addition to this, in 2013 the National Institute of Health has funded around USD1.3 million stem cell researches.

Adult stem cell leads the market due to low contamination during sub-culture and expansion, relatively low labor production and compatibility with the human body. Induced pluripotent stem cells are expected to report revenue of over USD 4.5 billion by 2020, on account of analogous nature of its origin.

Different types of technologies include cell acquisition, cryopreservation, cell production, expansion and sub-culture. For any technique in stem cell production, stem cell acquisition is the basic step; hence, this segment is likely to dominate the market with revenues estimated at USD 10.9 billion by 2020.

Application of stem cell in regenerative medicines is exponentially increasing and hence dominates the market as compared to its application in drug discovery and medicine. Geographical presence of stem cell market is in North America, Asia Pacific, Europe and rest of the world. North America held the largest industry share due to huge government funding and initiative for stem cell research and rise in the acceptance of stem cell therapies.

However, Asia-Pacific is expected to be the fastest growing segment with a CAGR of over 25.0% due to rising contract research outsourcing and medical tourism. Key industry contributors include Advanced Cell Technology Inc., CellartisAB, Cellular Engineering Technologies Inc., BioTime Inc. and International Stem Cell Corporation.

In March 2015, International Stem Cell Corporation received patent from Japan for it human cell bank production from pathogenically activated eggs. This is in alignment with the companies' strategy to make its intellectual property position strong and also develop relationship with Japan. Moreover, in June 2015, Cellaris AB launched a new xeno free culture called Cellartis EF-CS.

Factors such as government funding, key player engagement to update the techniques, collaboration with domestic players for country specific market entry are expected to boom the stem cell market.

Grand View Research has segmented the global stem cells market on the basis of product, application, technology and region:

  • Stem Cells Product Outlook 
    • Stem Cells Platforms
      • Sequence Analysis Platforms
    • Adult Stem Cells
      • Hematopoietic Stem Cells
      • Mesenchymal Stem Cells
      • Neuronal Stem Cells
      • Dental Stem Cells
      • Umbilical Cord Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • Stem Cells Application Outlook 
    • Regenerative Medicine
      • Neurology
      • Orthopedics
      • Oncology
      • Hematology
      • Cardiovascular and Myocardial Infraction
      • Injuries
      • Diabetes
      • Liver Disorder
      • Incontinence
      • Others (Crohn's Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
    • Drug Discovery and Development
  • Stem Cells Technology Outlook 
    • Cell Acquisition
      • Bone Marrow Harvest
      • Apheresis
      • Umbilical Blood Cord
    • Cell Production
      • Therapeutic Cloning
      • In Vitro Fertilization
      • Isolation
      • Cell Culture
    • Cryopreservation
    • Expansion and Sub-Culture
  • Stem Cells Regional Outlook 
    • North America
    • Europe
    • Asia Pacific
    • RoW

Browse related reports by Grand View Research: 





About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs - mediafound.org, divog.org, ni2014.org  

Contact: 

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com  



'/>"/>
SOURCE Grand View Research, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
2. Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes
3. Cardium Reports On Potential Use Of Excellagen To Repair Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells
4. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
5. Neuralstem CEO To Present At Stem Cells & Regenerative Medicine Congress
6. Skin Cells Can Be Engineered Into Pulmonary Valves for Pediatric Patients
7. Study Determines MiMedx Allograft Effectively Recruits Circulating Stem and Progenitor Cells
8. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020: Transparency Market Research
9. The New Age of Regenerative Medicine: Are Stem Cells the Future of Healing?
10. Global Quantum Dot (Display, Medical Devices, Batteries, Solar Cells, Sensors, and Others) Market 2015-2020 with QD Vision, Nanosys & Nanoco Group Dominating
11. WuXi PharmaTech To Build New Cell Therapy Manufacturing Facility for CAR T Cells and Other Cancer Immunotherapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2018)... (PRWEB) , ... October 18, 2018 , ... ... housing, and human services provider, will celebrate 30 years of service to New ... at Columbia University, hosted by Bevy Smith. , Harlem United will honor ...
(Date:10/18/2018)... ... October 18, 2018 , ... The American ... the Centers for Medicare & Medicaid Services (CMS) to develop pathology-related quality measures ... CMS’ Quality Payment Program (QPP). ASCP is among seven awardees – and the ...
(Date:10/17/2018)... (PRWEB) , ... October 17, 2018 , ... ... Various methods of connection to your video conferencing platform and intuitive adjustments maximize ... single button for selecting the desired auscultation area on the body, which automatically ...
Breaking Medicine Technology:
(Date:10/16/2018)... MOINES, Iowa (PRWEB) , ... October 16, 2018 ... ... in Turbomachinery Train Optimization Services for upstream, midstream and downstream operators today announces ... TTCR 14.1 is a packaged release of critical system components focused on improving ...
(Date:10/16/2018)... ... ... dicentra Global Certifications, an affiliate of dicentra Cannabis Consulting, has announced the release of ... country in the world to formally legalize the recreational production and use of cannabis. ... use of cannabis edibles. , More than one in four Canadians aged 25 to ...
(Date:10/16/2018)... LOS ANGELES (PRWEB) , ... October 16, 2018 ... ... conference announced today that it will host the proceedings of the 4th Annual ... speak at this symposium that runs Wednesday, May 22, 2019, through Friday, May ...
(Date:10/13/2018)... ... October 13, 2018 , ... This World Food Day – Tuesday, October ... possible to end hunger by 2030 by breaking a GUINNESS WORLD RECORDS title with ... 28 U.S. based locations and five international locations together to break the GUINNESS WORLD ...
(Date:10/11/2018)... (PRWEB) , ... October 11, 2018 , ... ... remains “insecure and quite vulnerable to manipulation,” warns former U.S. Department of Homeland ... Elections: Why We’re Vulnerable and How We Can Stop it. , Pointing to ...
Breaking Medicine News(10 mins):